Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Edwards Lifesciences Corp (NYSE:EW)

120.15
Delayed Data
As of Jun 23
 +1.62 / +1.37%
Today’s Change
81.12
Today|||52-Week Range
121.75
+28.23%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line391.7M811.1M494.9M569.5M
 
 
 
 
 
Depreciation68.7M68.6M65.8M71.2M
 
 
 
 
 
Total Other Cash Flow-9.3M23.4M19.6M35.0M
 
 
 
 
 
Funds From Operations451.2M832.0M485.3M638.3M
 
 
 
 
 
Funds From/For Other Operating Expenses-21.5M-190.3M-64.4M-66.1M
 
 
 
 
 
Net Cash Flow - Operating Activities472.7M1.0B549.7M704.4M
 
 
 
 
 
 
InvestingIncrease In Investments-827.6M-2.1B-1.3B-1.1B
 
 
 
 
 
Decrease In Investments526.7M1.6B1.4B1.1B
 
 
 
 
 
Capital Expenditures-109.0M-82.9M-102.7M-176.1M
 
 
 
 
 
Fixed Asset Disposal2.3M3.1M2.4M--
 
 
 
 
Net Assets From Acquisitions 0.00-15.0M-331.6M0.00
 
 
 
Other Investing - Uses-4.0M-10.8M0.00-1.2M
 
 
 
 
Other Investing - Sources----0.002.4M
 
 
Net Cash Flow Investing-412.7M-633.0M-316.1M-211.7M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings1.3B226.3M31.4M253.5M
 
 
 
 
 
Long Term Debt Reduction-895.4M-239.0M-29.5M-31.4M
 
 
 
 
 
Net Proceeds Stock Sale45.5M113.3M87.2M103.3M
 
 
 
 
 
Common Preferred Redeemed-496.9M-300.9M-280.1M-662.3M
 
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing76.7M49.4M41.3M68.4M
 
 
 
 
 
Other Uses - Financing0.002.1M8.9M--
 
 
 
Net Cash Flow - Financing34.9M-153.0M-158.6M-268.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash14.6M-2.9M-10.4M-12.5M
 
 
 
 
 
 
Net Change In Cash94.9M236.3M75.0M224.2M